Coagulation 2 Flashcards

1
Q

What are antiphospholipid antibodies?

A

IgG, IgM or IgA antibodies directed against proteins that bind to phospholipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What detects antiphospholipid antibodies?

A
  1. Activity tests for lupus anticoagulants

2. Measuring antibodies by ELISA tests (anticardolipin ab, antibeta 2 glycoprotein Ab)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you make a laboratory diagnosis of Lupus anticoagulants?

A
  1. Prolongation of a phospholipid dependent clotting assay (PTT, DRVVT)
  2. Evidence of inhibitor shown by mixing studies
  3. evidence of phospholipid dependence
  4. lack of specific inhibition on any one coagulation factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do you diagnosis antiphospholipid syndrome?

A

need at least 1 clinical and 1 lab criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are hte clinical criteria for antiphospholipid syndrome?

A

– Occurrence of thrombotic event – venous or arterial

– Recurrent miscarriage, fetal death, premature birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the lab criteria for antiphosphlipid syndrome?

A

– Lupus anticoagulant (LAC)
– Anti-cardiolipin (IgG or IgM)
– Anti-Beta 2 glycoprotein (IgG or IgM)
– Perform testing on two or more occasions, 12 weeks apart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What factors and inhibitors are vitamin K dependent?

A

II, VII, IX, X

Protein C and S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the structure of vitamin K dependent factors and inhibitors? What are the reaction dependent on?

A

contain 9-11 glutamic acids

  • form gamma- carboxyglutamic acid tail
  • bind factors to phospholpid surfaces through Ca

Vit K (warfarin blocks recycling of vitamin K)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of action of warfarin?

A

it inhibits vit K1,2,3 expoxide reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does warfarin do?

A

reduces vitamin K dependent factor activity (II, VII, IX, X, C and S)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What vit K dependent factors have the shortest half life?

A

VII, Protein C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you monitor warfarin?

A

PT/INR

Or measure a vit K dependent factor, like X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the mechanism of heparin?

A

Antithrombin binds to a pentasaccharide structure on heparin resulting in a conformational changes which enhances antithrombin activity
– for thrombin inhibition needs an additional site on heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What factors does heparin inhibit?

A

IIa, IXa, Xa, XIa, XIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does HIT occur?

A

antibody causes platelet activation that leads to thrombosis and thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do you monitor heparin?

A
  1. aPTT
  2. anti-XA heparin level assay (chromogenic assay)
  3. Activated clotted time

NOT a Factor X level
Heparin
• Free AT + HeparinAT-HepAT-Hep + FXa (reagent)AT-Hep-Fxa + excess Fxa Residual FXa + substratechromogenic signal

17
Q

What is too sensitive to use for monitoring of heparin?

A

thrombin time

18
Q

enoxaparin, dalteparin, tinzaparin

A

LMWH

fractionated forms of heparin

19
Q

How does LMWH differ from heparin?

A
  • fractionated
  • Less plasma protein binding
  • 2-4 fold increase in factor Xa inhibition and less thrombin inhibition
20
Q

How do you monitor LMWH?

A

anti-XA assay (NOT aPTT)

4 hours after dose

21
Q

What are indirect Xa inhibitors?

A

fondaparinux

22
Q

What are direct Xa inhibitors?

A

– Rivaroxaban
– Apixaban
– Edoxaban

23
Q

What is the mechanism of fondaparinux?

A

Selective inhibition of activated Factor X
• Synthetic pentasaccharide sequence required to promote the binding of antithrombin to Factor Xa
• Induces conformational change in ANTITHROMBIN increases its affinity for Factor Xainhibition of Factor Xa decreased thrombin generation and thrombus development

24
Q

How is fondaparinux given? How is it monitored?

A

subcutaneously

Modified anti-Xa assays

25
Q

What is the mechanism of direct factor Xa inhibiotrs?

A

directly inhibit the active site of Xa (small molecules that do not require a cofactor)

26
Q

What do direct Xa inhibotrs inhibit?

A

– Free Factor Xa
– Factor Xa in the prothrombinase complex
• This Factor Xa is protected from inhibition by antithrombin
– Clot associated Factor Xa

27
Q

do direct Xa inhibitors need to be monitored?

A

NO!

28
Q

What anticoagulant binds to the active site and exosite 2 of thrombin?

A

heparin

29
Q

What anticoagulant binds to the active site and exosite 1 of thrombin?

A

bivalent DTI: bivalirudin, lepirudin

30
Q

What thrombin inhibotrs just bind to the active site?

A

argatroban

dabigatran

31
Q

How do you monitor direct thrombin inhibitors?

A

– APTT
– ACT
– Other assays = ecarin clot time, dilute
thrombin time, hemoclot assay, chromogenic assays

32
Q

Why monitor an anticoagulant?

A
  • Variable pharmacokinetics
  • Patient compliance
  • Emergency settings
  • Changes in renal or hepatic function • Interacting medications